Literature DB >> 16240989

Barriers to gene delivery using synthetic vectors.

Martin L Read1, Ann Logan, Leonard W Seymour.   

Abstract

Progress has been made in the development of different types of nucleic acids such as DNA and siRNA with the potential to form the basis of new treatments for genetic and acquired disorders. The lack of suitable vectors for the delivery of nucleic acids, however, represents a major hurdle to their continued development and therapeutic application. Synthetic vectors based on polycations are promising vectors for gene delivery as they are relatively safe and can be modified by the incorporation of ligands for targeting to specific cell types. However, the levels of gene expression mediated by synthetic vectors are low compared to viral vectors. The aim of this chapter is to give an overview of the main barriers that have been identified as limiting gene transfer using polycation-based synthetic vectors. The chapter is divided into two sections to focus on both extracellular and intracellular barriers. We describe novel strategies that are being used to develop increasingly sophisticated vectors in an attempt to overcome these barriers. For instance, we describe approaches to prolong the plasma circulation of polyplexes by the incorporation onto their surface of hydrophilic polymers such as polyethylene glycol (PEG) and poly[N-(2-hydroxypropyl)methacrylamide] (pHPMA). In addition, strategies to improve transfer of nucleic acids from the outside of the cell to the nucleus are described to overcome barriers such as escape from endocytic vesicles and translocation across the nuclear membrane. Furthermore, we highlight new types of vectors based on reducible polycations that are triggered by the intracellular environment to facilitate efficient cytoplasmic release of nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240989

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  16 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 2.  Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.

Authors:  Azam Bolhassani; Shabnam Javanzad; Tayebeh Saleh; Mehrdad Hashemi; Mohammad Reza Aghasadeghi; Seyed Mehdi Sadat
Journal:  Hum Vaccin Immunother       Date:  2013-10-15       Impact factor: 3.452

Review 3.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.

Authors:  Christopher L Grigsby; Kam W Leong
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

4.  Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.

Authors:  Sushma Kommareddy; Mansoor Amiji
Journal:  Nanomedicine       Date:  2007-03       Impact factor: 5.307

5.  Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.

Authors:  Da Li; Qing-qing Wang; Gu-ping Tang; Hong-liang Huang; Fen-ping Shen; Jing-zhong Li; Hai Yu
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

6.  Mg2+-induced DNA compaction, condensation, and phase separation in gene delivery vehicles based on zwitterionic phospholipids: a dynamic light scattering and surface-enhanced Raman spectroscopic study.

Authors:  Erhan Süleymanoğlu
Journal:  J Biol Inorg Chem       Date:  2017-09-18       Impact factor: 3.358

7.  Recognition and suppression of transfected plasmids by protein ZNF511-PRAP1, a potential molecular barrier to transgene expression.

Authors:  Guo-Hua Qiu; Carol Ho-Wing Leung; Tong Yun; Xiaojin Xie; Mirtha Laban; Shing Chuan Hooi
Journal:  Mol Ther       Date:  2011-05-03       Impact factor: 11.454

8.  Polymeric Materials for Gene Delivery and DNA Vaccination.

Authors:  David N Nguyen; Jordan J Green; Juliana M Chan; Robert Longer; Daniel G Anderson
Journal:  Adv Mater       Date:  2008-12-04       Impact factor: 30.849

9.  The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.

Authors:  Ying Wu; Weiwei Wang; Yinting Chen; Kaihong Huang; Xintao Shuai; Qikui Chen; Xuexian Li; Guoda Lian
Journal:  Int J Nanomedicine       Date:  2010-03-09

10.  PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expression.

Authors:  Sanjib Khargharia; Koby Kizzire; Mark D Ericson; Nicholas J Baumhover; Kevin G Rice
Journal:  J Control Release       Date:  2013-06-02       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.